Home
Conditions
Lymphoma, Extranodal NK-T-Cell

Clinical trial condition

Lymphoma, Extranodal NK-T-Cell

Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.

160 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Extranodal NK-T-Cell trial results

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types

NCT03012620

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +37 more
Locations: Gustave Roussy Cancer Campus Villejuif, France

View Trial Details

Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

Abramson Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

NCT01523223

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), +82 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Completed

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

NCT00577798

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiac Toxicity, +55 more
Locations: University of Nebraska Medical Center, Eppley Cancer Center Omaha, Nebraska, United States

View Trial Details

Completed

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

NCT00611351

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Unversity of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

NCT01336920

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +22 more
Locations: Emory University, Winship Cancer Institute Atlanta, Georgia, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

NCT00390117

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +40 more
Locations: Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

NCT03049449

Conditions: Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Copanlisib and Gemcitabine in Relapsed/Refractory PTCL

NCT03052933

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Chonnam National University Hwasun Hospital Hwasun-gun, Jeollanam-do, South Korea

View Trial Details

Lymphoma, Extranodal NK-T-Cell

Lymphoma, Extranodal NK-T-Cell trial results

Related conditions